v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net revenues $ 3,169,920 $ 7,180
Operating expenses:    
Direct costs of revenue 1,903,936
Research and development 30,000 165,360
Management contingent share plan 18,878 32,551
Selling, general and administrative 2,764,086 987,937
Total operating expenses 4,716,900 1,185,848
Loss from operations (1,546,980) (1,178,668)
Change in fair value of warrant liabilities 31,594 9,090
Interest expense (889,792) (301,912)
Gain from extinguishment of Senior PIK Notes 1,863,834
Other non-operating expense, net (79,464) (32,500)
Total non-operating income (expense), net 926,172 (325,322)
Loss before income taxes (620,808) (1,503,990)
Provision for income taxes
Net loss, including noncontrolling interest (620,808) (1,503,990)
Noncontrolling interest 4,350
Net loss attributable to FOXO (616,458) (1,503,990)
Deemed dividends from the issuances of preferred stock and the triggers of down round provisions and extension of Assumed Warrants (172,125) (656,164)
Net loss to common stockholders (788,583) (2,160,154)
Preferred stock dividends – undeclared (314,909)
Net loss to common stockholders, net of preferred stock dividends – undeclared $ (1,103,492) $ (2,160,154)
Common Class A [Member]    
Operating expenses:    
Net loss per share of Class A common stock, basic $ (0.73) $ (4.82)
Net loss per share of Class A common stock, diluted $ (0.73) $ (4.82)
Weighted average shares of Class A common stock, basic 1,506,959 448,117
Weighted average shares of Class A common stock, diluted 1,506,959 448,117